(Q44314786)

1 December 2017

title

Carboxypeptidase B inhibitors reduce tissue factor-induced renal microthrombi in rats (English)

1 reference

1 December 2017

Yuko Muto

1

1 reference

1 December 2017

Kokichi Suzuki

series ordinal

2

1 reference

1 December 2017

Eriko Sato

series ordinal

3

1 reference

1 December 2017

Hidemi Ishii

series ordinal

4

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

European Journal of Pharmacology

1 December 2017

published in

1 reference

1 December 2017

volume

461

1 reference

1 December 2017

issue

2-3

1 reference

1 December 2017

page(s)

181-189

1 reference

Treatment of disseminated intravascular coagulation (DIC) with all-trans retinoic acid in an endotoxin-induced rat model

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901297-4

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901297-4

TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901297-4

Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901297-4

Regulation of blood coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901297-4

Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901297-4

Effects of a highly selective synthetic inhibitor of plasma kallikrein on disseminated intravascular coagulation in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901297-4

Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901297-4

An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901297-4

A potent mercapto bi-product analogue inhibitor for human carboxypeptidase N

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901297-4

Plasma carboxypeptidases as regulators of the plasminogen system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901297-4

Basic principles in thrombolysis: regulatory role of plasminogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901297-4

Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901297-4

The sepsis-coagulant axis: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901297-4

10.1016/S0014-2999(03)01297-4

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference